Effect of NVP-BEZ235, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, on radiosensitivity of oral cancer cell line through G2/M phase checkpoint regulation. This is an ASCO ...
The data published in Scientific Reports are the first to implicate a role for RASGRP4 mutations in B-cell malignancies. Relapsed/refractory diffuse large B-cell lymphoma (rrDLBCL) is associated with ...
Progression-free survival (PFS) from a phase I study of crizotinib (PF-02341066) in patients with ALK-positive non-small cell lung cancer (NSCLC). This is an ASCO Meeting Abstract from the 2011 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback